Biogen Alzheimer’s drug skips to Phase 3 testing
December 02, 2014 at 12:01 PM EST
A new Alzheimer’s treatment from Biogen Idec is showing enough promise to leap past a testing step.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.